1. Home
  2. SYBX vs NWGL Comparison

SYBX vs NWGL Comparison

Compare SYBX & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • NWGL
  • Stock Information
  • Founded
  • SYBX N/A
  • NWGL 2008
  • Country
  • SYBX United States
  • NWGL Macau
  • Employees
  • SYBX N/A
  • NWGL N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • SYBX Health Care
  • NWGL
  • Exchange
  • SYBX Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • SYBX 20.0M
  • NWGL 22.8M
  • IPO Year
  • SYBX N/A
  • NWGL 2023
  • Fundamental
  • Price
  • SYBX $1.75
  • NWGL $1.20
  • Analyst Decision
  • SYBX
  • NWGL
  • Analyst Count
  • SYBX 0
  • NWGL 0
  • Target Price
  • SYBX N/A
  • NWGL N/A
  • AVG Volume (30 Days)
  • SYBX 50.2K
  • NWGL 15.5K
  • Earning Date
  • SYBX 11-11-2025
  • NWGL 11-29-2025
  • Dividend Yield
  • SYBX N/A
  • NWGL N/A
  • EPS Growth
  • SYBX N/A
  • NWGL N/A
  • EPS
  • SYBX N/A
  • NWGL N/A
  • Revenue
  • SYBX N/A
  • NWGL $21,539,347.00
  • Revenue This Year
  • SYBX N/A
  • NWGL N/A
  • Revenue Next Year
  • SYBX N/A
  • NWGL N/A
  • P/E Ratio
  • SYBX N/A
  • NWGL N/A
  • Revenue Growth
  • SYBX N/A
  • NWGL N/A
  • 52 Week Low
  • SYBX $0.90
  • NWGL $0.91
  • 52 Week High
  • SYBX $1.96
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 49.98
  • NWGL 38.84
  • Support Level
  • SYBX $1.52
  • NWGL $1.30
  • Resistance Level
  • SYBX $1.86
  • NWGL $1.30
  • Average True Range (ATR)
  • SYBX 0.12
  • NWGL 0.10
  • MACD
  • SYBX -0.01
  • NWGL -0.03
  • Stochastic Oscillator
  • SYBX 42.86
  • NWGL 11.49

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: